Crossref
journal-article
Elsevier BV
Neuron (78)
References
67
Referenced
366
10.1006/jmcc.2002.2082
/ J. Mol. Cell. Cardiol. / Cardiac energy metabolism homeostasis: role of cytosolic calcium by Balaban (2002)10.1006/nbdi.1999.0276
/ Neurobiol. Dis. / Functional phenotype in transgenic mice expressing mutant human presenilin-1 by Barrow (2000)10.1038/35036035
/ Nat. Rev. Mol. Cell Biol. / The versatility and universality of calcium signalling by Berridge (2000)10.1016/S0140-6736(06)69113-7
/ Lancet / Alzheimer's disease by Blennow (2006)10.1523/JNEUROSCI.2177-05.2005
/ J. Neurosci. / Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory by Buckner (2005)10.1073/pnas.91.10.4489
/ Proc. Natl. Acad. Sci. USA / Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner by Buxbaum (1994)10.1074/jbc.M313296200
/ J. Biol. Chem. / Activity-dependent expression of inositol 1,4,5-trisphosphate receptor type 1 in hippocampal neurons by Cai (2004)10.1074/jbc.M112117200
/ J. Biol. Chem. / The presenilin 1 deltaE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations by Cedazo-Minguez (2002)10.1074/jbc.M000040200
/ J. Biol. Chem. / Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons by Chan (2000)10.1016/j.neuron.2005.10.028
/ Neuron / Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo by Cirrito (2005)10.1038/nm0197-67
/ Nat. Med. / Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice by Citron (1997)10.1038/sj.embor.7400897
/ EMBO Rep. / Loss-of-function presenilin mutations in Alzheimer disease. Talking point on the role of presenilin mutations in Alzheimer disease by De Strooper (2007)10.1038/ncb960
/ Nat. Cell Biol. / Reconstitution of gamma-secretase activity by Edbauer (2003)10.1006/nbdi.1998.0176
/ Neurobiol. Dis. / Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families by Etcheberrigaray (1998)10.1152/physrev.00035.2006
/ Physiol. Rev. / Inositol trisphosphate receptor Ca2+ release channels by Foskett (2007)10.1038/nm1006-1121
/ Nat. Med. / Alzheimer disease: presenilin springs a leak by Gandy (2006)10.1073/pnas.96.10.5797
/ Proc. Natl. Acad. Sci. USA / Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons by Genazzani (1999)10.1016/j.nbd.2004.10.016
/ Neurobiol. Dis. / Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia by Giacomello (2005)10.1097/00001756-199612200-00074
/ Neuroreport / Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide by Guo (1996)10.1038/nrm2101
/ Nat. Rev. Mol. Cell Biol. / Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide by Haass (2007)10.1016/j.neuron.2006.09.016
/ Neuron / A hundred years of Alzheimer's disease research by Hardy (2006)10.1126/science.1072994
/ Science / The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics by Hardy (2002)10.1016/j.nbd.2004.08.002
/ Neurobiol. Dis. / Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity by Hebert (2004)10.1016/0197-4580(96)00074-7
/ Neurobiol. Aging / Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease by Hirashima (1996)10.1093/hmg/6.10.1639
/ Hum. Mol. Genet. / The presenilins and Alzheimer's disease by Hutton (1997)10.1113/jphysiol.2006.109504
/ J. Physiol. / Graded recruitment and inactivation of single InsP3 receptor Ca2+-release channels: implications for quantal Ca2+ release by Ionescu (2006)10.1073/pnas.91.2.534
/ Proc. Natl. Acad. Sci. USA / Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease by Ito (1994)10.1016/j.neulet.2005.10.088
/ Neurosci. Lett. / Calcium oscillations in type-1 astrocytes, the effect of a presenilin 1 (PS1) mutation by Johnston (2006)10.1074/jbc.273.22.14015
/ J. Biol. Chem. / Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons by Jolly-Tornetta (1998)10.1016/S0896-6273(03)00124-7
/ Neuron / APP processing and synaptic function by Kamenetz (2003)10.1016/j.ceca.2006.03.005
/ Cell Calcium / Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells by Kasri (2006)10.1038/nrn960
/ Nat. Rev. Neurosci. / Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease by LaFerla (2002)10.1016/j.ceca.2005.04.001
/ Cell Calcium / Rapid functional assays of recombinant IP3 receptors by Laude (2005)10.1074/jbc.274.46.32535
/ J. Biol. Chem. / Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4,5-trisphosphate-mediated calcium signals by Leissring (1999)10.1046/j.1471-4159.1999.0721061.x
/ J. Neurochem. / Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes by Leissring (1999)10.1083/jcb.149.4.793
/ J. Cell Biol. / Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice by Leissring (2000)10.1006/nbdi.2001.0382
/ Neurobiol. Dis. / Subcellular mechanisms of presenilin-mediated enhancement of calcium signaling by Leissring (2001)10.1016/j.cellsig.2004.09.005
/ Cell. Signal. / The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells by Lessard (2005)10.1073/pnas.95.26.15821
/ Proc. Natl. Acad. Sci. USA / Inositol 1,4,5-trisphosphate activation of inositol trisphosphate receptor Ca2+ channel by ligand tuning of Ca2+ inhibition by Mak (1998)10.1038/nature02621
/ Nature / Pathways towards and away from Alzheimer's disease by Mattson (2004)10.1002/(SICI)1097-4547(19971115)50:4<505::AID-JNR1>3.0.CO;2-I
/ J. Neurosci. Res. / Cell and molecular neurobiology of presenilins: a role for the endoplasmic reticulum in the pathogenesis of Alzheimer's disease? by Mattson (1997)10.1016/S0143-4160(03)00128-3
/ Cell Calcium / Neuronal and glial calcium signaling in Alzheimer's disease by Mattson (2003)10.1523/JNEUROSCI.20-04-01358.2000
/ J. Neurosci. / Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis by Mattson (2000)10.1152/physrev.1990.70.2.391
/ Physiol. Rev. / Role of calcium ions in regulation of mammalian intramitochondrial metabolism by McCormack (1990)10.1016/S0091-679X(03)01007-0
/ Methods Cell Biol. / Culturing hippocampal and cortical neurons by Meberg (2003)10.1172/JCI30447
/ J. Clin. Invest. / Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1 by Nelson (2007)10.1152/ajpcell.00508.2005
/ Am. J. Physiol. Cell Physiol. / Effect of gamma-secretase inhibitors on muscarinic receptor-mediated calcium signaling in human salivary epithelial cells by Oh (2006)10.1021/bi00181a016
/ Biochemistry / Calcium ionophore increases amyloid beta peptide production by cultured cells by Querfurth (1994)10.1038/nm0896-864
/ Nat. Med. / Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease by Scheuner (1996)10.1074/jbc.M010977200
/ J. Biol. Chem. / Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation by Schneider (2001)10.1073/pnas.0608332104
/ Proc. Natl. Acad. Sci. USA / The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism by Shen (2007)10.1016/S0006-8993(02)02970-0
/ Brain Res. / Ca2+ stores and capacitative Ca2+ entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation by Smith (2002)10.1016/j.ceca.2005.06.021
/ Cell Calcium / Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals by Smith (2005)10.1111/j.1471-4159.2005.03332.x
/ J. Neurochem. / Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease by Smith (2005)10.1177/1073858404270899
/ Neuroscientist / Calcium dysregulation, IP3 signaling, and Alzheimer's disease by Stutzmann (2005)10.1523/JNEUROSCI.4386-03.2004
/ J. Neurosci. / Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer's-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability by Stutzmann (2004)10.1523/JNEUROSCI.0739-06.2006
/ J. Neurosci. / Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice by Stutzmann (2006)10.1093/emboj/16.11.3078
/ EMBO J. / Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor by Sugawara (1997)10.1074/jbc.M606736200
/ J. Biol. Chem. / Amyloid-beta-(1–42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice by Supnet (2006)10.1126/science.8191290
/ Science / An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants by Suzuki (1994)10.1096/fj.05-3744fje
/ FASEB J. / Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signaling by Takeda (2005)10.1016/j.cell.2006.06.059
/ Cell / Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations by Tu (2006)10.1152/physrev.00004.2004
/ Physiol. Rev. / Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons by Verkhratsky (2005)10.1038/ncb1302
/ Nat. Cell Biol. / The endoplasmic reticulum gateway to apoptosis by Bcl-XL modulation of the InsP3R by White (2005)10.1016/S0896-6273(00)00066-0
/ Neuron / Presenilin-mediated modulation of capacitative calcium entry by Yoo (2000)10.1016/j.nbd.2003.11.002
/ Neurobiol. Dis. / The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores by Zatti (2004)10.1016/j.ceca.2006.03.002
/ Cell Calcium / Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels by Zatti (2006)
Dates
Type | When |
---|---|
Created | 17 years, 2 months ago (June 26, 2008, 5:01 a.m.) |
Deposited | 6 years, 3 months ago (May 12, 2019, 6:11 a.m.) |
Indexed | 2 months ago (July 4, 2025, 12:31 a.m.) |
Issued | 17 years, 3 months ago (June 1, 2008) |
Published | 17 years, 3 months ago (June 1, 2008) |
Published Print | 17 years, 3 months ago (June 1, 2008) |
@article{Cheung_2008, title={Mechanism of Ca2+ Disruption in Alzheimer’s Disease by Presenilin Regulation of InsP3 Receptor Channel Gating}, volume={58}, ISSN={0896-6273}, url={http://dx.doi.org/10.1016/j.neuron.2008.04.015}, DOI={10.1016/j.neuron.2008.04.015}, number={6}, journal={Neuron}, publisher={Elsevier BV}, author={Cheung, King-Ho and Shineman, Diana and Müller, Marioly and Cárdenas, César and Mei, Lijuan and Yang, Jun and Tomita, Taisuke and Iwatsubo, Takeshi and Lee, Virginia M.-Y. and Foskett, J. Kevin}, year={2008}, month=jun, pages={871–883} }